Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

What is Paxlovid? Everything you need to know about the antiviral Covid drug being taken by Joe Biden

Late-stage clinical trial found nearly 90 per cent effectiveness from antiviral pill

The Independent UK

President Joe Biden tests positive for COVID-19

White House Press Secretary Karine Jean-Pierre said that President Biden was experiencing “mild symptoms” and has begun taking Paxlovid, an antiviral drug designed to reduce the severity of the disease.

Chicago Sun-Times

Pfizer fined £63 million for overcharging NHS for life-saving medication

The Competition and Markets authority said that the ‘excessive’ price hikes by Pfizer and Flynn had meant that ‘patients and taxpayers lost out’

Chronicle Live

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer slapped with £63 million fine by CMA

Pharma firm Flynn was also charged £6.7 million as part of the CMA investigation

Evening Standard

Watchdog fines Pfizer and Flynn £70m for overcharging NHS for epilepsy drug

Penalties come after an in-depth investigation carried out by the Competition and Markets Authority

The Guardian - UK

The morning symptom which means you should 'assume you have Covid'

A leading Covid scientist said twice as many people have coronavirus as the common cold.

Daily Record

Pfizer (PFE), BioNTech Seek EU Nod For Omicron-Based COVID Jab

Pfizer (NYSE: PFE) and its partner, BioNTech (NASDAQ: BNTX) announced that they have completed the submission of a regulatory application to the European Medicines Agency (EMA), which seeks authorization for thei

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The morning symptom which means you should 'assume you have covid'

Twice as many people currently have covid as have the common cold as cases rocket

Wales Online

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.

WEKU

Novavax COVID shot for adults gains CDC advisers’ backing

Novavax Inc.’s shares surged after its COVID-19 vaccine won backing from a panel of U.S. public health advisers, a crucial step in providing officials with another tool against the virus as cases start to rise again.

Tribune News Service

CDC endorses new Novavax Covid vaccine

Two-dose shot will becomes fourth one to gain full approval later this week

The Independent UK

CDC advisers endorse more traditional Novavax COVID shot

Government advisers say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax

The Independent UK

COVID-19 antiviral prescriptions hard to fill, Qld medical body says, as demand ramps up

Patients with prescriptions for antiviral drugs after catching COVID-19 are struggling to get them filled at pharmacies across Queensland, a medical association says, as increased illegibility increases demand on stocks.

ABC News

A dire moment in the pandemic ... was the chance he'd been waiting for

How Sotiris Missailidis, head of R&D in Brazil's vaccine agency, used the COVID crisis to push through a game-changing effort for middle-income countries to invent their own mRNA vaccine.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Covid vaccine protection ‘short lived,’ booster doses essential, study confirms

‘Continual updating of our vaccinations and booster shots is critical,’ scientists say

ABC News

Australia has ordered millions more COVID vaccines than it needs. What are the options to deal with them?

Australia has used less than a quarter of the hundreds of millions of COVID-19 vaccine doses it bought. What will happen to the rest?

Orlando Sentinel

When can we stop worrying about COVID-19? Not yet, experts say

ORLANDO, Fla. — Scientists have suggested that once vaccines and treatment for COVID-19 became widely available, a surge might not require more than the basic precautions practiced during flu season. With the development of vaccines, pre-exposure treatment such as Evushield and post-exposure treatment such as Paxlovid, it’s natural to ask…

The Hindu

Bhutan-China ties won’t harm India’s interests: Bhutan Foreign Minister

After over two years of COVID-19-induced lockdown, Bhutan will open its doors for tourists on September 23 with a new expensive policy for international tourists and Indians as well. Bhutan Foreign Minister Tandi Dorji says the lessons of COVID-19 include better ties with neighbours, including China.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 16 strange trades.

Tribune News Service

Vaccine uptake slow as cases among youngest children rise

ATLANTA — Sesame Street’s Elmo, who is 3½, recently got his COVID-19 vaccine.

Inverse

First study of its kind reports on period changes post-Covid-19 vaccination

A survey of 39,000 people who currently or formerly menstruate found that 42 percent of respondents had irregular or breakthrough bleeding after a COVID vaccine.

Benzinga

Novavax (NVAX) Down As EU Adds Side Effects To COVID Jab Label

Shares of Novavax (NASDAQ: NVAX) fell 26.2% on Jul 14, after the European Medicines Agency's (TSE: EMA) Pharmacovigilance Risk Assessment Committee ("PRAC") updated the product label of Nuvaxovid, the company's COVID-19 vaccine, to include some potential side effects like severe aller

WEKU

The omicron subvariant dominating U.S. COVID-19 cases is more vaccine-resistant

The BA.5 strain represented 65% of cases from July 3 to 9, according to data from the Centers of Disease Control and Prevention.

ABC News

COVID-19 vaccines targeting the Omicron variant are on the way — but it could be worth getting a fourth dose now

Omicron is now the dominant strain of COVID-19 around the world and boosters targeting this variant are getting closer to being released.

Benzinga

What Are Whales Doing With Pfizer

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 11 strange trades.

1 … 43 44 45 46

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.